“A recent World Health Organization report estimates that 1 in 10 medical products – including pills, vaccines, and diagnostic kits – circulating in low and middle-income countries are either substandard or falsified. This counterfeit issue is growing exponentially worldwide and impacts the U.S. health system as well.  In this second module of the Life Sciences Forum, explore the challenges and solutions – including identifying diversion/insertion points, following the API, examining import/export records, and harnessing social media information – to safeguarding the pharmaceutical supply chain.”

Alanna Lavelle
Catherine Begley, Merck



Share This